DrugPatentWatch Database Preview
Profile for Canada Patent: 2514897
US Patent Family Members and Approved Drugs for Canada Patent: 2514897
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Feb 13, 2023 | Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride |
➤ Try a Free Trial | Apr 3, 2024 | Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride |
➤ Try a Free Trial | Feb 14, 2022 | Indivior Inc | SUBOXONE | buprenorphine hydrochloride; naloxone hydrochloride |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |